Cargando…
Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence
[Image: see text] Tuberculosis (TB), entrained by Mycobacterium tuberculosis, continues to be an enfeebling disease, killing nearly 1.5 million people in 2019, with 2 billion people worldwide affected by latent TB. The multidrug-resistant and totally drug-resistant emerging strains further exacerbat...
Autores principales: | Chhabra, Sonali, Kumar, Sunil, Parkesh, Raman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190903/ https://www.ncbi.nlm.nih.gov/pubmed/34124465 http://dx.doi.org/10.1021/acsomega.1c01314 |
Ejemplares similares
-
Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
por: Bhutani, Isha, et al.
Publicado: (2015) -
Virtual Screening of Small Molecular Inhibitors against DprE1
por: Zhang, Gang, et al.
Publicado: (2018) -
Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
por: Chikhale, Rupesh V, et al.
Publicado: (2014) -
Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis
por: Xiang, Wang, et al.
Publicado: (2023) -
Discovery of Novel
Thiophene-arylamide Derivatives
as DprE1 Inhibitors with Potent Antimycobacterial Activities
por: Wang, Pengxu, et al.
Publicado: (2021)